Govig Life Sciences Division’s expertise spans all multiple segments of life sciences, including Biotech, Pharma, Medical Devices, Diagnostics, Digital Therapeutics, Wearables, Radiopharmaceuticals, and other emerging service and product sectors. Through our expertise and successful placement activity, we help build your organization by addressing your needs now and throughout its life cycle. Emerging and midsized clients repeatedly retain us when they face tight timelines, knowledge and network gaps, resource constraints, or challenges related to scope and reputation. We put our tenure, relationships, and expertise to work so you can meet your deadlines, keep your promises to patients and investors, and build a successful organization. Learn more at https://govig.com/industry/life-sciences/

PCM Trials has been at the forefront of decentralized clinical research since 2008, leading mobile visits and recently introducing community-based research sites. We are driving the shift to patient-centric clinical trials, giving individuals the flexibility to engage in research studies in ways that work best for them. Our approach expands opportunities for participation, resulting in greater patient diversity, reduced patient dropout, and faster study results. For more information, visit https://pcmtrials.com/.

For more information, please visit https://www.mgc.co.jp/eng/

For more information, please visit https://www.nelsonlabs.com/

For more information, please visit https://www.nanomi.com/

Origins is the global patient focused specialist consultancy that provides industry-leading insights and strategic counsel for our clients at critical decision points in drug development and commercialisation. To learn more, please visit www.origins-patients.com

NeoGenomics specializes in premier cancer solutions. We partner with pharmaceutical clients from discovery to commercialization with our broad oncology testing capabilities powered by in-house scientific expertise and dedicated project support teams. Our clients benefit from our state-of-the-art molecular technology, from whole exome sequencing, whole transcriptome sequencing, HLA typing, and the proprietary MultiOmyx™ high-order multiplexing methodology. We are the trusted experts with over 20 years of experience helping navigate the increasingly complex cancer landscape. For more information, visit https://neogenomics.com.

STEMCELL Technologies provides extensive cell culture and isolation tools for stem cell and immunology research. Driven by science and a passion for quality, STEMCELL Technologies manufactures products for immune cell isolation, activation, and expansion to advance cancer research and immunotherapy development. For more information, visit https://www.stemcell.com/

PhaseV is a technology company leveraging advanced causal inference and machine learning to innovate clinical trials. Our technology and methods enable us to optimize trial design by detecting hidden signals in existing clinical data and extracting actionable insights, as well as supporting advanced adaptive designs for more efficient, precise and successful clinical trials. For more information, please visit https://phasevtrials.com/

Aixial is a global, therapeutically focused Clinical Research Organization with extensive expertise in the immuno-oncology therapeutic area. Since 2002, the company has been a trusted partner in the rapidly evolving immuno-oncology field.

Aixial’s team is experienced in managing the complexities of immuno-oncology trials, from Phase I first in human through post marketing.  By offering flexible clinical trial services we accelerate development by augmenting client teams with experts, enabling robust clinical outcomes, and helping clients navigate the challenges of bringing new cancer therapies to market. For more information, visit https://www.aixialgroup.com/

For more information, please visit https://www.ashland.com/

Standard BioTools delivers the leading omics solutions that empower life sciences researchers to discover unique biological insights not accessible by other technologies. Our high-content platforms in affinity-based, spatial and single-cell proteomics and multi-omics offer the highest levels of precision and unique scalability in the life sciences industry. Integration of highly multiplexed single-cell proteomics using CyTOF™ technology with the plasma-based and spatial proteomic modalities of SomaScan™ and Hyperion™ platforms provides characterization of multiple interconnected biological systems and their interactions, leading to a deeper understanding of response and discovery of critical biomarkers that together can form highly predictive signatures. For more information, visit https://www.standardbio.com/